Biodefense threats are too numerous and mutable for us to develop advance countermeasures against them all. Developing countermeasures upon emergence is also infeasible‚Äîto many people die in the interim. Lumen offers a third path: a rapid, inexpensive platform for making safe, effective biologic drugs, on demand.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 8
Organization Type: Commercial Startup (C+)
Market Keywords: Therapeutics, treatments, preventatives